Phase III clinical trials for Abdala vaccine candidate authorized
The phase III trial for Abdala, from the Center for Genetic Engineering and Biotechnology (CIGB), will take place in the provinces of Granma, Santiago de Cuba and Guantánamo between March 22 and April 9.
La entrada Phase III clinical trials for Abdala vaccine candidate authorized se publicó primero en OnCubaNews English.
Comments
Comments for this post are closed.